be_ixf;ym_202201 d_22; ct_50

Select Page

Paul Mampilly
IPO Speculator

IPO Speculator

Wall Street has brainwashed investors into believing that making fortunes investing in IPOs is reserved for an insider elite …

That the truly ground-floor opportunities are just too difficult, too risky, too unknown to the average investor.

But nothing could be further from the truth.

Because the fact is, 9-times out of 10, IPOs fall below their IPO price … leaving “insiders” holding the bag.

Yet, over time more than half of all IPOs go up 100% or more and 10% go up 900% or more. And if you can catch a new offering at what I call its “Alpha Moment,” the profits can be life-changing.

On average, 20 companies come to market each and every month. That means 24 companies will hit their “Alpha Moment” in the next year. This affords six-figure profit opportunities on even the smallest stake.

And that’s what I’m going to bring to you in IPO Speculator.

The key is my 25-point IPO rating system. My team of analysts and I devoted countless hours of research, combing through thousands of data points, spending an embarrassing sum of money on Wall Street’s IPO-centric research organization …

And we identified the golden thread … the DNA of the most-profitable IPO opportunities. Plus, the timing indicators to nail their “Alpha Moments.”

For example, my historical analysis pinpointed a medical diagnostics company called Semler Scientific. Wall Street’s top clients … those with privileged access … scooped up shares at IPO setting themselves up for a triple-digit gain. But those who jumped in at our “Alpha Moment” earned three-times the average profit – over 3,200%.

Lantheus Holdings is another example. The Wall Street elite who got in at IPO have made a solid triple-digit gain. But those who waited for our “Alpha Moment” set themselves up for returns much greater than that.

There are so many examples in my research — and I’m excited to get you started.

With IPO Speculator, you’ll receive the following:


Paul Mampilly
Editor, IPO Speculator

Read IPO Speculator subscriber reviews and testimonials here.

Share This